• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
WEB
Click for more information
0.97% $7.17

WEB TRAVEL GROUP LIMITED - News & Media

Market Cap $2.816B  ! watchlist Created with Sketch. Add to my watchlist
Consumer Cyclical Lodging

WEB Travel Group Limited, formerly Webjet Limited, is an Australia-based global business... WEB Travel Group Limited, formerly Webjet Limited, is an Australia-based global business to business (B2B) travel distribution company. The Company connects travel sellers with travel buyers across all major global markets. WebBeds, its brand, is a global online marketplace for the travel trade, an intermediary connecting hotels and other travel service suppliers to a distribution network of travel buyers all over the world. WebBeds sources room inventory from worldwide hotels, then connects, aggregates and merchandises that inventory as bookable product in its platform, the WebBeds Global Marketplace, and distributes it to a global network of travel trade buyers, who sell to the travelling public. Global and regional hotel chains, resorts, transfer and sightseeing companies and more - can sell their products through WebBeds by connecting to a diversified global network of over 44,000 travel buyers in 139 source markets. It also offers application programming interface connectivity.More

Articles & Videos

Oz air travel has returned to pre-COVID norms – and Webjet shares show it

Webjet (ASX:WEB) shares jumped as much as +13% in the first hour of trade on record earnings and a new corporate spinoff strategy.

22 May 2024 11:24 (AEST)



(20min delay)
Last
$7.17 		Change
-0.070(0.97%) 		Mkt cap ! $2.816B
Open High Low Value Volume
$7.20 $7.21 $7.15 $759.0K 105.8K

Buyers (Bids)

No. Vol. Price($)
15 3697 $7.17
 

Sellers (Offers)

Price($) Vol. No.
$7.18 2038 9
View Market Depth
Last trade - 11.05am 02/10/2024 (20 minute delay) ?
Last
$7.15 		  Change
-0.070 ( 0.92 %)
Open High Low Volume
$7.16 $7.21 $7.15 19320
Last updated 11.24am 02/10/2024 ?
WEB (ASX) Chart

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Maximus jumps 7% as it unveils latest gold drill hits at Eagles Nest; grades up to 15g/t Maximus Resources (ASX:MXR) has unveiled its latest drilling assay results at Eagles Nest, hitting gold downhole multiple assets.
PainChek close to finding out if FDA approves its flagship app for use in dementia care PainChek (ASX:PCK) has updated the market on the progress of its De Novo submission to the US FDA for its flagship app in aged care settings.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.